Latest News

Tired of market volatility? These three Canadian blue-chip stocks are pivoting from steady income plays to growth engines for 2026 and the rest of the decade.

Given their stable cash flows, high yields, and healthy growth prospects, these two Canadian stocks can deliver stable and reliable passive income.

This engineering and infrastructure firm saw a notable insider sale after its stock price skyrocketed.

Taxpayers are seeing larger-than-normal refunds for tax year 2025.

This ETF is built to outperform in down markets.

SoFi's current price doesn't reflect its earnings trajectory. Here's what the numbers actually show.

This diagnostic imaging and AI firm disclosed a notable insider sale, as filings highlight steady performance in the healthcare sector.

Discover a TFSA stock offering a dependable 7% yield and consistent monthly income backed by a stable, grocery‑anchored real estate portfolio.

These two Canadian growth stocks might be setting up for an excellent year of trading on the TSX with massive gains. Here’s what you should know.

Don't overlook this incredibly useful savings account.

CrowdStrike will profit from the growth of the cloud, cybersecurity, and AI markets.

The young biopharma outfit's growth potential continues to expand.

These growth stocks are backed by solid underlying fundamentals, experiencing solid demand, and could outperform the broader market.

Here are two high-growth stock candidates for long-term investors with a high-risk tolerance.

With all eyes on the Middle East, these energy stocks could be smart buys today.

Some key clinical trial data is expected soon.

Alibaba's cloud intelligence segment grew 36% in its latest quarter, but the company's e-commerce business is struggling.

The company is much more exposed to oil prices than you might think.

FuboTV executed a reverse-split today, but its stock may be a deep value.

Volatility isn't a reason to make rash decisions.

This week will be a pivotal one for the oil market.

The Federal Open Market Committee left interest rates unchanged at its recent meeting.

AbbVie has strong financials, a great dividend, and its stock trades at a modest valuation.

Boost your portfolio with sustainable passive income.